PG
CLB icon

Pendal Group’s Core Laboratories CLB Stock Holding History

Pendal Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,958
Closed -$20.2K – 443
2020
Q1 		$20.2K Sell
1,958
-1
-0.1% -$28 ﹤0.01% 426
2019
Q4 		$73.8K Sell
1,959
-16
-0.8% -$719 ﹤0.01% 429
2019
Q3 		$92.1K Sell
1,975
-157
-7% -$7.3K ﹤0.01% 431
2019
Q2 		$111K Sell
2,132
-119
-5% -$6.98K ﹤0.01% 411
2019
Q1 		$155K Sell
2,251
-37
-2% -$2.48K ﹤0.01% 415
2018
Q4 		$137K Buy
+2,288
New +$197K ﹤0.01% 402

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Pendal Group's CLB Position: Q2 2020 in Review

Pendal Group sold out of Core Laboratories (CLB) in Q2 2020, closing a stake of 1,958 shares — an estimated $20.2K sold.

Pendal Group first reported a position in CLB in Q4 2018 and held it in 6 quarters. The position peaked at $155K in Q1 2019. 197 funds tracked by Wall St. Rank hold CLB as of Q2 2020.

  • Pendal Group reported no remaining Core Laboratories position as of Q2 2020 after selling out during the quarter.
  • Pendal Group sold 1,958 Core Laboratories shares in Q2 2020, an estimated $20.2K.
  • Pendal Group first reported a position in Core Laboratories in Q4 2018 and held it in 6 quarters.
  • Pendal Group's Core Laboratories position peaked at $155K in Q1 2019.
  • 197 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2020.

Based on Pendal Group's 13F filing for Q2 2020, filed 7 Aug 2020.